HR 4104 would expand access to Medicaid, CHIP, and Affordable Care Act (ACA) health coverage for immigrants lawfully present in the U.S., including those with deferred action or pending immigration applications. It removes state-level barriers to Medicaid/CHIP eligibility for lawfully present individuals, treats Federally authorized presence as "lawfully present" for ACA subsidies, and allows states to choose to cover undocumented individuals through Medicaid or CHIP. The bill also extends these changes to Medicare Part A and Part B, ensuring lawfully present immigrants qualify for coverage and subsidies under existing programs. These provisions apply to all federally funded health programs and take effect in 2026 for most ACA-related changes.
The PROTECT for Rare Act (S 3551) requires Medicare, Medicaid, and private health insurers to establish an expedited appeal process for coverage denials of drugs treating rare diseases or conditions affecting 200,000 or fewer U.S. individuals. It expands coverage criteria by allowing insurers to consider peer-reviewed medical literature and clinical guidelines - not just FDA-approved labeling - as valid justification for treatment, while excluding uses listed as contraindicated in approved drug labeling or medical references. The law applies to all covered drugs used for rare conditions and takes effect for coverage decisions starting January 1, 2027. This directly affects patients with rare diseases, healthcare providers seeking coverage approvals, and insurers managing drug benefit denials.
Essential Caregivers Act of 2025 This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods. Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.
Treat and Reduce Obesity Act of 2025 This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner. The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
The Rural Health Sustainability Act of 2025 modifies Medicare rules to change how hospitals qualify as "rural emergency hospitals." It adds a new requirement that hospitals must first have been designated as rural by the Health Resources and Services Administration's Office of Rural Health Policy. This change affects hospitals seeking this specific Medicare designation, which is needed to receive certain reimbursement rates for rural emergency services. The bill also adjusts the effective date of existing criteria to January 1, 2014, but the key new provision focuses on the HRSA designation requirement.
This bill establishes MED Grants for medical students who commit to 10 years of primary care practice, DENTAL Grants for dental students who commit to 10 years of rural practice, and NURSE Grants for nursing students. It authorizes $2.8 billion for medical school enrollment expansion (50% increase by year 2), $1.98 billion for nursing schools (30% increase by year 2), and $615 million for dental schools (20% increase by year 2) over fiscal years 2026-2035. The bill also allocates 5,022 additional Medicare residency positions annually (with 15% for psychiatry and 30% for primary care) and increases teaching health center funding with annual increases starting at $892.5 million in 2026. Additionally, it creates a $1.8 billion rural relocation grant program to help health care professionals move to rural areas with a 3-year commitment requirement.
This bill would deny federal tax deductions for medical expenses related to gender transition procedures and prohibit federal funding through Medicaid, Medicare, and essential health benefits for such procedures. It defines gender transition procedures broadly to include various hormonal treatments and surgeries, while excluding certain medical conditions like disorders of sex development and specific medical emergencies. The bill would affect individuals seeking gender transition care who rely on federal health programs for coverage. The provisions would apply to services furnished after the bill's enactment, with specific exclusions for certain medically necessary treatments.
The ALS Better Care Act amends Medicare to cover a specific set of ALS-related services - including specialized physician support, therapy, equipment coordination, and respiratory care - for patients diagnosed with ALS, starting January 1, 2027. Medicare will pay providers a single, annual amount per patient visit (beginning at $800 in 2027), adjusted yearly based on cost increases or recommendations from the Comptroller General. The bill also requires a report on challenges in funding and staffing ALS clinical trials to improve research progress. This addresses current low Medicare reimbursements that have caused long wait times and limited care access for ALS patients.
The Patients Deserve Price Tags Act requires hospitals, clinical diagnostic laboratories, imaging services providers, and ambulatory surgical centers to publicly disclose detailed pricing information for healthcare services in machine-readable formats. This includes standard charges, discounted cash prices, payer-specific negotiated rates, and other relevant pricing data that consumers can easily access and compare. The law applies to all facilities that provide services to Medicare beneficiaries, with implementation dates starting in 2026 for hospitals and 2027 for other providers. Non-compliant facilities face daily civil monetary penalties ranging from $300 to $10,000 per day, depending on facility size and duration of non-compliance.
This bill requires the Medicare program to audit prior authorization rules for high-cost items and drugs by 2027, identifying those needing excessive paperwork steps. By 2028, it mandates standardized prior authorization rules across all Medicare Advantage plans for these specific items and drugs. The law exempts providers in certain risk-based care models (like accountable care organizations) from these standardized requirements. It directly affects Medicare Advantage enrollees and plans by simplifying paperwork for certain treatments and medications. The bill aims to reduce administrative burdens for providers and patients without changing coverage decisions.
